# A Rare Case of Cutaneous Leiomyosarcoma Arising From the External Auditory Canal

**Authors:** Jun Yamashita, Shinsuke Ide, Kei Kajihara, Takeshi Nakamura, Kuniyuki Takahashi

PMC · DOI: 10.7759/cureus.102558 · Cureus · 2026-01-29

## TL;DR

A rare case of cutaneous leiomyosarcoma in the ear of a young woman is reported, with successful surgical removal and no recurrence after five months.

## Contribution

The paper presents a rare clinical case of cutaneous LMS in the external auditory canal with detailed diagnostic and treatment insights.

## Key findings

- The tumor was confined to the cartilaginous part of the external auditory canal with no bony infiltration.
- Histopathology confirmed FNCLCC Grade 2 LMS with moderate atypia and 30%-40% necrosis.
- Postoperative imaging showed no recurrence at five months, despite inadequate safety margins.

## Abstract

Leiomyosarcoma (LMS) is a malignant tumor that originates from smooth muscle. Cutaneous LMS is a distinct, superficial sarcoma that arises from dermal smooth muscle. It generally has a more favorable prognosis than subcutaneous or deep soft tissue LMS. Head and neck LMS accounts for a small proportion of all LMS cases, and primary tumors in the external auditory canal are extremely rare.

We report a case of cutaneous LMS arising from the external auditory canal. The patient was a 32-year-old woman. She presented with a two-month history of a left external auditory canal mass, hearing loss, and ear pain. Contrast-enhanced CT and MRI revealed a 17-mm tumor confined to the cartilaginous portion of the external auditory canal, with no obvious infiltration into the bony portion. Biopsy results showed features of a smooth muscle tumor, and the level of Ki-67 expression led to a diagnosis of LMS. We resected the tumor via a preauricular incision and a longitudinal incision of the external auditory canal, including the external auditory canal cartilage, the surrounding soft tissue, and part of the temporomandibular joint capsule. Histopathology revealed tumor cells with moderately atypical, spindle-shaped nuclei arranged in fasciculated patterns. Necrosis was observed at a rate of 30%-40%, and mitotic cells were observed at a rate of 5 per 10 high-power fields. This led to a diagnosis of Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) Grade 2 LMS. Tumor cells were noted near the resection margin, and the safety margin appeared inadequate. Postoperative epithelialization of the external auditory canal was favorable, and no recurrence was detected on contrast-enhanced CT at five months.

Although there is no established treatment strategy for head and neck soft tissue sarcomas, complete resection with adequate margins is essential. However, achieving adequate surgical margins is challenging due to functional and cosmetic considerations in the head and neck region. As in this case, small, brownish LMS are clinically considered to be cutaneous LMS, which generally have a relatively good prognosis. Close follow-up is required in cases involving resection close to the margin, and adjuvant therapies such as radical resection or radiation should be considered if recurrence occurs. A treatment strategy tailored to the tumor type and resection margin is necessary for primary LMS of the head and neck region.

## Linked entities

- **Diseases:** Leiomyosarcoma (MONDO:0005058)

## Full-text entities

- **Genes:** MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, MIB1 (MIB E3 ubiquitin protein ligase 1) [NCBI Gene 57534] {aka DIP-1, DIP1, LVNC7, MIB, ZZANK2, ZZZ6}, CD34 (CD34 molecule) [NCBI Gene 947], ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, VIM (vimentin) [NCBI Gene 7431]
- **Diseases:** smooth muscle tumor (MESH:D018235), Necrosis (MESH:D009336), skin defect (MESH:D012868), papillomas (MESH:D010212), nevi (MESH:D009506), soft tissue tumors (MESH:D012983), facial nerve palsy (MESH:D005155), GIST (MESH:D046152), metastasis (MESH:D009362), hearing difficulties (MESH:D034381), Soft tissue sarcomas (MESH:D012509), squamous cell carcinoma (MESH:D002294), balance disorders (MESH:D009358), osteomas (MESH:D010016), mesenchymal tumors (MESH:C535700), cholesteatomas (MESH:D002781), Cancer (MESH:D009369), Head and neck LMS (MESH:D006258), external auditory canal mass (MESH:C566245), ear pain (MESH:D010031), Cutaneous LMS (MESH:D007890), pain (MESH:D010146)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949592/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949592/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949592/full.md

---
Source: https://tomesphere.com/paper/PMC12949592